Bosentan in essential hypertension [2] (multiple letters)

New England Journal of Medicine

Volumn 339, Issue 5, 1998, Pages 346-347

  Haynes, W G ^a   Ferro, C J ^a   Webb, D J ^a   Kramer, B K ^a   Schweda, F ^a   Riegger, G A J ^a   Krum, H ^a   Lacourciere, Y ^a   Charlon, V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; ANTIHYPERTENSIVE AGENT; ENDOTHELIN 1; SULFONAMIDE;

BLOOD PRESSURE REGULATION; DOSE RESPONSE; DRUG EFFECT; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; RECEPTOR BLOCKING; VASODILATATION; BLOOD PRESSURE; DRUG ANTAGONISM; NOTE; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; ENDOTHELIN-1; HUMANS; HYPERTENSION; RECEPTORS, ENDOTHELIN; SULFONAMIDES; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032581586     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199807303390513     Document Type: Letter

References (0)